AAAAAA
Results:
1-14
|
Results: 14
Authors:
Reblin, T
Donarski, N
Fineder, L
Brasen, JH
Dieplinger, H
Thaiss, F
Stahl, RAK
Beisiegel, U
Wolf, G
Citation: T. Reblin et al., Renal handling of human apolipoprotein(a) and its fragments in the rat, AM J KIDNEY, 38(3), 2001, pp. 619-630
Authors:
Kalina, A
Csaszar, A
Fust, G
Nagy, B
Szalai, C
Karadi, I
Duba, J
Prohaszka, Z
Horvath, L
Dieplinger, H
Citation: A. Kalina et al., The association of serum lipoprotein(a) levels, apolipoprotein(a) size and(TTTTA)(n) polymorphism with coronary heart disease, CLIN CHIM A, 309(1), 2001, pp. 45-51
Authors:
Kronenberg, F
Stuhlinger, M
Trenkwalder, E
Geethanjali, FS
Pachinger, O
von Eckardstein, A
Dieplinger, H
Citation: F. Kronenberg et al., Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease, J AM COL C, 36(3), 2000, pp. 751-757
Authors:
Bottcher, A
Schlosser, J
Kronenberg, F
Dieplinger, H
Knipping, G
Lackner, KJ
Schmitz, G
Citation: A. Bottcher et al., Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions, J LIPID RES, 41(6), 2000, pp. 905-915
Authors:
Niemeier, A
Willnow, T
Dieplinger, H
Jacobsen, C
Meyer, N
Hilpert, J
Beisiegel, U
Citation: A. Niemeier et al., Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro, ART THROM V, 19(3), 1999, pp. 552-561
Authors:
Kronenberg, F
Neyer, U
Lhotta, K
Trenkwalder, E
Auinger, M
Pribasnig, A
Meisl, T
Konig, P
Dieplinger, H
Citation: F. Kronenberg et al., The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: A prospective follow-up, J AM S NEPH, 10(5), 1999, pp. 1027-1036
Authors:
Schwelberger, HG
Dieplinger, H
Kohlwein, SD
Citation: Hg. Schwelberger et al., Diamine oxidase and catalase are expressed in the same cells but are present in different subcellular compartments in porcine kidney, INFLAMM RES, 48, 1999, pp. S81-S82
Authors:
Dieplinger, H
Utermann, G
Citation: H. Dieplinger et G. Utermann, The seventh myth of lipoprotein(a): where and how is it assembled?, CURR OP LIP, 10(3), 1999, pp. 275-283
Authors:
Kronenberg, F
Auinger, M
Dieplinger, H
Citation: F. Kronenberg et al., Genetic epidemiology of the apolipoprotein(a) polymorphism and its role inrenal diseases and Type-I diabetes mellitus, ACT MED AUS, 26(5), 1999, pp. 142-147
Authors:
Dieplinger, H
Citation: H. Dieplinger, Lipoprotein(a) in health and disease, BIOCH SOC T, 27(4), 1999, pp. 439-447
Authors:
Dieplinger, H
Kronenberg, F
Citation: H. Dieplinger et F. Kronenberg, Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 2), WIEN KLIN W, 111(2), 1999, pp. 46-55
Authors:
Dieplinger, H
Kronenberg, F
Citation: H. Dieplinger et F. Kronenberg, Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1), WIEN KLIN W, 111(1), 1999, pp. 5-20
Authors:
Kerschdorfer, L
Konig, P
Neyer, U
Bosmuller, C
Lhotta, K
Auinger, M
Hohenegger, M
Riegler, P
Margreiter, R
Utermann, G
Dieplinger, H
Kronenberg, F
Citation: L. Kerschdorfer et al., Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up, ATHEROSCLER, 144(2), 1999, pp. 381-391
Authors:
Kronenberg, F
Auinger, M
Trenkwalder, E
Irsigler, K
Utermann, G
Dieplinger, H
Citation: F. Kronenberg et al., Is apolipoprotein(a) a susceptibility gene for Type I diabetes mellitus and related to long-term survival?, DIABETOLOG, 42(8), 1999, pp. 1021-1027
Risultati:
1-14
|